P666: 1 YEAR RESULTS OF DASATINIB 70MG/DAY VERSUS 100MG/DAY IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE(CML-CP):A PROSPECTIVE RANDOMIZED CONTROLLED STUDY.

Detalles Bibliográficos
Autores principales: Yu, Dan, Cheng, Hui, Guo, Jingming, Jiang, Rui, Zhang, Youshan, Wan, Chucheng, Qin, Jun, Yuan, Guolin, Chen, Shiming, Yang, Zhuangzhi, Hu, Junbin, Zhang, Yicheng, LI, Weiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429722/
http://dx.doi.org/10.1097/01.HS9.0000969568.85601.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429722/
http://dx.doi.org/10.1097/01.HS9.0000969568.85601.05

Ejemplares similares